-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
StockWatch: CytomX Shares Yo-Yo on Colorectal Cancer Data
CytomX Therapeutics (NASDAQ: CTMX) drew attention a few days ago after its six-year-old, up-to-$1.68 billion cancer collaboration with Astellas Pharma (Tokyo: 4503) was terminated by the...
-
Nature – Synthetic Biology2 weeks ago
Engineering ligands for theophylline riboswitches expands its regulatory dynamic range in prokaryotic and eukaryotic systems
Post Content
-
Nature – Synthetic Biology2 weeks ago
Analysis of heterocycle formation and stereochemical control by a non-ribosomal peptide synthetase condensation domain
Post Content
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Novartis Acquires Pikavation for up to $3B, Expanding Cancer Pipeline
Novartis has committed up to $3 billion—two-thirds of that upfront—toward acquiring Pikavation Therapeutics, a subsidiary of Synnovation Therapeutics that specializes in developing PI3Kα inhibitor programs designed...
-
Fierce Biotech2 weeks ago
NIH grant cuts hit women, early-career scientists the hardest: analysis
Last year’s funding cuts at the National Institutes of Health disproportionately impacted women and early-career researchers, according to a new analysis, raising questions about what the...
-
ScienceDaily – Biotechnology2 weeks ago
Hidden antibiotics in river fish spark new food safety fears
Antibiotics are accumulating in a major Brazilian river, especially during the dry season when pollution becomes more concentrated. Scientists even detected a banned drug inside fish...
-
Endpoints News2 weeks ago
Roche, Nvidia’s ‘AI Factory’; Industry looks to soften MFN impact; Structure’s oral GLP-1 data; and more
Welcome to another edition of Endpoints Weekly — and happy spring! The weather may not feel very spring-like here in NYC (outside that false start a...
-
STAT News – Biotech3 weeks agoSTAT+: Automatic enrollment in Medicare Advantage plans under consideration, top Trump health official says
President Trump’s Medicare director said Thursday his team is considering a policy that would automatically enroll Medicare beneficiaries into Medicare Advantage plans, a controversial idea that...
-
GEN – Genetic Engineering & Biotechnology News3 weeks ago
Engineered Esophagus Rebuilds Missing Organ Segment in Pig Models
A new Nature Biotechnology paper describes the process of engineering a lab-grown esophagus that can safely replace a full section of the native organ and restore...
-
STAT News – Biotech3 weeks agoSTAT+: Iran war has not disrupted pharma supply chains. That could change if conflict is prolonged
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but with no clear end in sight, the potential...
Terns rebuffed a higher bid before selling to Merck
